Giuffre Randall Michael bought DMAC
January 2, 2026 · Form 4 insider transaction
Giuffre Randall Michael bought 6,175 shares of DiaMedica Therapeutics Inc. at $8.42 per share, a transaction worth $52.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,175
Price
$8.42
Total value
$52.0K
InsiderGiuffre Randall Michael
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after398,587
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $52,000. The deferred stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026.